Crosstalk between PTEN/Akt2 and TGFβ signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model

Cancer Science

Volumn 100, Issue 5, 2009, Pages 813-820

  Taniai, Eriko ^a   Kawai, Masaomi ^a,b   Dewa, Yasuaki ^a,b   Nishimura, Jihei ^a,b   Harada, Tomoaki ^a   Saegusa, Yukie ^a,b   Matsumoto, Sayaka ^a,b   Takahashi, Miwa ^c   Mitsumori, Kunitoshi ^a   Shibutani, Makoto ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FENBENDAZOLE; GLUTATHIONE TRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PIPERONYL BUTOXIDE; PROTEIN KINASE B BETA; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE MODEL; ENZYME PHOSPHORYLATION; FISCHER 344 RAT; IMMUNOLOCALIZATION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; PEPTIDES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RATS; RATS, INBRED F344; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 65349115941     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01120.x     Document Type: Article

References (43)

1. Shirai T. A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential, a historical review of model development and summary of results from 291 tests. Toxicol Pathol 1997; 25: 453-60.
2. Ito N, Imaida K, Asamoto M, Shirai T. Early detection of carcinogenic substances and modifiers in rats. Mutat Res 2000; 462: 209-17.
3. Miller RT, Cattley RC, Marsman DS, Lyght O, Popp JA. TGFα differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Carcinogenesis 1995; 16: 77-82.
4. Van Gijssel HE, Ohlson LC, Torndal UB et al. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo. Hepatology 2000; 32: 701-10.
5. Finnberg N, Silins I, Stenius U, Högberg J. Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions. Carcinogenesis 2004; 25: 113-22.
6. Ogawa K, Asamoto M, Suzuki S, Tsujimura K, Shirai T. Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions. Med Mol Morph 2005; 38: 23-9.
7. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: More than just a road to PKB. Biochem J 2000; 346: 561-76.
8. Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu Rev Biochem 2001; 70: 247-79.
9. West KA, Castillo SS, Dennis PA. Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 2002; 5: 234-48.
10. Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 2004; 90: 2-8.
11. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes Dev 1999; 13: 2905-27.
12. Silins I, Högberg J, Stenius U. Dietary sphingolipids suppress a subset of preneoplastic rat liver lesions exhibiting high PTEN, low phospho-Akt and high levels of ceramide species. Food Chem Toxicol 2006; 44: 1552-61.
13. Takahashi M, Shibutani M, Woo GH et al. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model. Carcinogenesis 2008; 29: 2218-26.
14. Zhang H, Bajraszewski N, Wu E et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest 2007; 117: 730-8.
15. Murillo MM, del Castillo G, Sánchez A, Fernández M, Fabregat I. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 2005; 24: 4580-7.
16. Shoda T, Onodera H, Takeda M et al. Liver tumor promoting effects of fenbendazole in rats. Toxicol Pathol 1999; 27: 553-62.
17. Muguruma M, Unami A, Kanki M et al. Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats. Toxicology 2007; 236: 61-75.
18. Kuroda K, Terao K, Akao M. Inhibitory effect of fumaric acid on hepatocarcinogenesis by thioacetamide in rats. J Natl Cancer Inst 1987; 79: 1047-51.
19. Shikano S, Coblitz B, Wu M, Li M. 14-3-3 proteins: Regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends Cell Biol 2006; 16: 370-5.
20. Powell DW, Rane MJ, Chen Q, Singh S, McLeish KR. Identification of 14-3-3ζ as a protein kinase B/Akt substrate. J Biol Chem 2002; 277: 21639-42.
21. Kebache S, Ash J, Annis MG et al. Grb10 and active Raf-1 kinase promote Bad-dependent cell survival. J Biol Chem 2007; 282: 21873-83.
22. Jahn T, Seipel P, Urschel S, Peschel C, Duyster J. Role for the adaptor protein Grb10 in the activation of Akt. Mol Cell Biol 2002; 22: 979-91.
23. Goetz CA, O'Neil JJ, Farrar MA. Membrane localization, oligomerization, and phosphorylation are required for optimal raf activation. J Biol Chem 2003; 278: 51184-9.
24. Kao G, Tuck S, Baillie D, Sundaram MVC. elegans SUR-6/PR55 cooperates with LET-92/protein phosphatase 2A and promotes Raf activity independently of inhibitory Akt phosphorylation sites. Development 2004; 131: 755-65.
25. Yamada E, Okada S, Saito T et al. Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. J Cell Biol 2005; 168: 921-8.
26. Lee KY, Shibutani M, Inoue K et al. Methacarn fixation -effects of tissue processing and storage conditions on detection of mRNAs and proteins in paraffin-embedded tissues. Anal Biochem 2006; 351: 36-43.
27. Ikeda H, Nishi S, Sakai M. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Biochem J 2004; 380: 515-21.
28. Dummler B, Hemmings BA. Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 2007; 35: 231-5.
29. Cheng GZ, Zhang W, Wang LH. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res 2008; 68: 957-60.
30. Luebeck EG, Buchmann A, Stinchcombe S, Moolgavkar SH, Schwarz M. Effects of 2,3,7,8-tetrachlorodibenzo-P-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model. Toxicol Appl Pharmacol 2000; 167: 63-73.
31. Kinoshita A, Wanibuchi H, Morimura K et al. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis 2003; 24: 1389-99.
32. Woodgett JR. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 2005; 17: 150-7.
33. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003; 425: 577-84.
34. MassaguéJ. TGFβ in cancer. Cell 2008; 134: 215-30.
35. Chow JY, Quach KT, Cabrera BL, Cabral JA, Beck SE, Carethers JM. RAS/ERK modulates TGFβ-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 2007; 28: 2321-7.
36. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275: 36803-10.
37. Vinals F, Pouysségur J. Transforming growth factor β1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling. Mol Cell Biol 2001; 21: 7218-30.
38. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 2008; 314: 3093-106.
39. Sorkin A, Waters CM. Endocytosis of growth factor receptors. Bioessays 1993; 15: 375-82.
40. Orth JD, Krueger EW, Weller SG, McNiven MA. A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. Cancer Res 2006; 66: 3603-10.
41. Montero AJ, Díaz-Montero CM, Mao L et al. Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer. Cancer Biol Ther 2006; 5: 1494-501.
42. Caja L, Ortiz C, Bertran E et al. Differential intracellular signaling induced by TGF-β in rat adult hepatocytes and hepatoma cells: Implications in liver carcinogenesis. Cell Signal 2007; 19: 683-94.
43. Kitano M, Ichihara T, Matsuda T et al. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis 1998; 19: 1475-80.